fashion -WSS

fashion

author：explore 2025-09-30 00:39:14 - browse：7315

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Oak Street deal isn't the answer to health care's woes

leisure time

WSS

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

6 phony surgeries that take placebo to the extreme

Free medical tuition alone isn't enough to close gaps in primary care

NIH study of ME/CFS points to clear biological hallmarks

With competition flaring, obesity drug hits goal in liver disease study

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

United colonoscopy coverage change 'may cost lives,' doctors say

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Moonlake's readout produced a cash windfall. Risks remain

The Harvard botanist who searched for psychedelics in the Amazon

Apple is now the first public company to be valued at $3 trillion

He's a Nobel laureate. Critics say he was misleading on Covid

leisure time

STAT readers on older presidents, polypills, Medicare, and more

Alabama IVF ruling threatens families facing fatal genetic disease

STAT reporters are Pulitzer Prize finalists for investigative reporting

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

NIH study of ME/CFS points to clear biological hallmarks

CVS is willing to dump 10% of its Medicare Advantage members

focus

leisure time

leisure time

leisure time